Skip to main content

Table 5 The levels of malondialdehyde (MDA), glutathione (GSH), as well as the activities of superoxide dismutase (SOD) and glutathione reductase (GR) in the liver of the control rats and those orally administrated PZA alone, NGN 1 h prior to PZA, and NGN alone, every day for 7, 14, 21 & 28 days. Data are displayed as mean (of 5 rats) ± standard error of mean

From: The protective effect of naringenin against pyrazinamide-induced hepatotoxicity in male Wistar rats

Parameter

Time

(days)

Experimental group

Treatment effect

Control

PZA

PZA + NGN

NGN

MDA

(mg g−1 liver)

7

5.30 ± 0.11a

5.28 ± 0.15a

5.35 ± 0.12a

5.35 ± 0.13a

F3, 16 = 0.078, P = 0.971

14

5.13 ± 0.08a

5.64 ± 0.16b

5.15 ± 0.08a

5.26 ± 0.10a

F3, 16 = 4.55, P = 0.017

21

5.16 ± 0.08a

7.70 ± 0.14b*

5.18 ± 0.07a

5.14 ± 0.10a

F3, 16 = 157.4, P = 0.000

28

5.30 ± 0.10a

8.28 ± 0.12b*

5.14 ± 0.07a

5.15 ± 0.08a

F3, 16 = 273.9, P = 0.000

r

 + 0.94

 − 0.35

 − 0.36

 
 

Time effect

F3, 16 = 0.907, P = 0.459

F3, 16 = 109.53, P = 0.000

F3, 16 = 1.295, P = 0.31

F3, 16 = 0.916, P = 0.455

 

GSH

(mg g−1 protein)

7

44.00 ± 1.53a

45.24 ± 1.30a

44.72 ± 1.38a

44.44 ± 1.14a

F3, 16 = 0.149, P = 0.929

14

45.38 ± 1.09b

41.10 ± 0.98a*

46.04 ± 1.02b

45.96 ± 1.16b

F3, 16 = 4.93, P = 0.013

21

45.06 ± 1.19b

34.92 ± 1.43a*

44.54 ± 1.38b

44.38 ± 1.06b

F3, 16 = 14.71, P = 0.000

28

46.04 ± 1.31b

30.90 ± 0.73a*

45.84 ± 1.11b

45.32 ± 1.20b

F3, 16 = 44.60, P = 0.000

r

 − 0.92

 + 0.081

 + 0.05

 
 

Time effect

F3, 16 = 0.433, P = 0.732

F3, 16 = 31.14, P = 0.000

F3, 16 = 0.384, P = 0.766

F3, 16 = 0.44, P = 0.727

 

SOD

(U g−1 protein)

7

9.41 ± 0.13a

9.31 ± 0.12a

9.30 ± 0.12a

9.34 ± 0.12a

F3, 16 = 0.145, P = 0.932

14

9.41 ± 0.08b

9.04 ± 0.05a

9.28 ± 0.11b

9.25 ± 0.12b

F3, 16 = 2.709, P = 0.08

21

9.39 ± 0.15b

7.33 ± 0.11a*

9.32 ± 0.12b

9.30 ± 0.14b

F3, 16 = 59.87, P = 0.000

28

9.48 ± 0.11b

7.19 ± 0.11a*

9.33 ± 0.14b

9.20 ± 0.10b

F3, 16 = 88.33, P = 0.000

r

 − 0.92

 + 0.056

 − 0.17

 
 

Time effect

F3, 16 = 0.101, P = 0.958

F3, 16 = 122.7, P = 0.000

F3, 16 = 0.031, P = 0.992

F3, 16 = 0.266, P = 0.849

 

GR

(U g−1 protein)

7

82.46 ± 1.03a

84.02 ± 1.38a

83.52 ± 1.27a

83.08 ± 1.04a

F3, 16 = 0.31, P = 0.818

14

82.64 ± 0.79a

81.94 ± 1.23a

83.54 ± 1.10a

83.52 ± 0.84a

F3, 16 = 0.587, P = 0.632

21

83.86 ± 1.13b

70.34 ± 0.90a*

83.70 ± 0.97b

83.66 ± 1.42b

F3, 16 = 35.74, P = 0.000

28

84.02 ± 0.72b

55.94 ± 1.60a*

83.22 ± 0.81b

83.12 ± 1.23b

F3, 16 = 144.8, P = 0.000

r

 − 0.93

 − 0.04

 + 0.01

 
 

Time effect

F3, 16 = 0.753, P = 0.536

F3, 16 = 98.41, P = 0.000

F3, 16 = 0.036, P = 0.99

F3, 16 = 0.063, P = 0.979

 
  1. P < 0.05, P < 0.01, P < 0.000: represents significant effects. *: represent significant (P < 0.05) differences as compared to 7th day
  2. r: Pearson’s correlation coefficient of the studied parameters with the experimental time
  3. In the same row, according to Duncan’s test, means marked with the same small superscript letters are insignificantly different (P > 0.05), whereas those marked with different ones are significantly different (P < 0.05)